A Phase III Prospective Double Blind Placebo Controlled Randomized Study of Adjuvant MEDI4736 In Completely Resected Non-Small Cell Lung Cancer
- 28/10/2018
- 3654
- Comments Off on CCTG BR.31
Randomized, Open Label, Phase 3 Trial of Neoadjuvant Nivolumab and Ipilimumab Plus Chemotherapy Versus Platinum Doublet Chemotherapy Alone in Early Stage NSCLC
- 28/10/2018
- 3340
- Comments Off on CCTG BR.31